Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Thoracic Neoplasms
>>
RET inhib
>>
Phase 3
Welcome,
Profile
Billing
Logout
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
4
8
12
16
20
24
28
32
36
40
sorafenib
/ Generic mfg.
Caprelsa
(vandetanib) / Sanofi
motesanib
(AMG 706) / Takeda
AiTan
(rivoceranib) / HLB Bio Group
Iclusig
(ponatinib) / Takeda, Otsuka
